$MGRX
Mangoceuticals, Inc. Common Stock
XNAS•Health Care•Services-Misc Health & Allied Services, Nec
$0.260
▲+0.81%+$0.002
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMangoceuticals, Inc. Common Stock
XNAS•Health Care•Services-Misc Health & Allied Services, Nec
Why is MGRX up today? It is at $0.260 (+0.81%), and our scanner flagged it 15 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment MGRX spikes, and full due diligence on MGRX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $MGRX 15 times in the last 30 days. Create a free account to track $MGRX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on MGRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MGRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystPriced share offering, from the latest SEC filing. Read it →Across every filing on file, supply equal to 115.5% of the tradeable float is in play - 115.5% more can still be issued.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
23,012,822 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $475K in size · Priced at $0.75/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cohen Jacob D. Officer | Sold (automatic/other) | -2.00M 9.3% of company | n/a | n/a | n/a | Aug 11, 26 |
Cohen Jacob D. Officer | Acquired (grant/award) | +2.00M 9.3% of company | added 100% | 3.31M | n/a | Aug 11, 26 |
Hamilton Alex P. Director | Acquired (grant/award) | +100K 0.5% of company | added 100% | 102K | n/a | Jul 28, 26 |
Cohen Jacob D. Officer | Acquired (grant/award) | +2.00M 9.3% of company | n/a | 2.00M | n/a | Jul 28, 26 |
Johnston Eugene M Officer | Acquired (grant/award) | +100K 0.5% of company | added 83% | 220K | n/a | Jul 28, 26 |
Johnston Eugene M Officer | Sold (automatic/other) | -3K 0.02% of company | sold 2.7% | 120K | $4K at $1.17 | Dec 15, 25 |
Johnston Eugene M Officer | Sold (automatic/other) | -5K 0.02% of company | sold 3.9% | 123K | $6K at $1.20 | Dec 9, 25 |
Johnston Eugene M Officer | Sold (automatic/other) | -10K 0.05% of company | sold 7.2% | 128K | $11K at $1.13 | Dec 5, 25 |
Hamilton Alex P. Director | Sold (automatic/other) | -125K 0.6% of company | sold 97% | 3K | $153K at $1.22 | Nov 19, 25 |
Cohen Jacob D. Officer | Sold (automatic/other) | -500K 2.3% of company | n/a | n/a | n/a | Sep 30, 25 |
Cohen Jacob D. Officer | Acquired (grant/award) | +500K 2.3% of company | added 62% | 1.30M | n/a | Sep 30, 25 |
D'Alessio Lorraine Pamela Director | Acquired (grant/award) | +100K 0.5% of company | added 100% | 137K | n/a | Sep 9, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in services-misc health & allied services, nec, closest in size first.
Here is the latest on MGRX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for MGRX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
MGRX last traded at $0.260, up 0.81% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Mangoceuticals, Inc. Common Stock (MGRX) is next expected to report earnings on Friday, November 13, 2026, about 15 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The MGRX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged MGRX 15 times in the last 30 days.
MGRX (Mangoceuticals, Inc. Common Stock) trades on XNAS, with a market cap of about $6M in the SERVICES-MISC HEALTH & ALLIED SERVICES, NEC sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge MGRX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$MGRX discussion
Sign in to ask a question or join the discussion.